Ligand validation:2R4E

IMD: IMIDAZOLE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
2R4E_IMD_B_1960	52%	79%	0.161	0.918	0.49	0.38	-	-	0	0	100%	1
2R4E_IMD_A_1957	32%	76%	0.18	0.852	0.35	0.58	-	-	1	0	100%	1
2R4J_IMD_A_1961	99%	75%	0.048	0.986	0.37	0.6	-	-	5	0	100%	1
2R45_IMD_B_912	58%	78%	0.171	0.949	0.58	0.33	-	-	0	0	100%	1
2R46_IMD_B_7068	52%	73%	0.193	0.953	0.48	0.57	-	-	2	0	100%	1
2QCU_IMD_A_807	32%	76%	0.159	0.829	0.38	0.56	-	-	0	0	100%	1
4RS3_IMD_A_413	100%	61%	0.034	0.994	0.77	0.71	-	-	0	0	100%	1
6THT_IMD_A_301	100%	89%	0.036	0.993	0.6	0.05	-	-	0	0	100%	1
5OKB_IMD_B_502	100%	75%	0.036	0.984	0.38	0.58	-	-	1	0	100%	1
6IJ1_IMD_A_402	100%	52%	0.036	0.984	0.55	1.27	-	-	1	0	100%	1
3U9W_IMD_A_2009	100%	54%	0.038	0.985	0.43	1.32	-	1	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.